Insider Trading & Ownership - Johnson David Michael

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Johnson David Michael
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-11-10
Purchase
2023-11-13
5:24 pm
Zentalis Pharmaceuticals Inc.ZNTLJohnson David Michael
Director
17,000$9.879$167,943144,389
(Direct)
View
2023-11-07
Purchase
2023-11-09
5:02 pm
Aura Biosciences Inc.AURAJohnson David Michael
Director
199,601$7.1893$1,434,987350,339
(Indirect
Direct)
View
2023-10-03
Purchase
2023-10-05
7:56 pm
Aura Biosciences Inc.AURAJohnson David Michael
Director
20,066$8.3811$168,175225,738
(Indirect
Direct)
View
2023-01-05
Purchase
2023-01-09
5:55 pm
Aura Biosciences Inc.AURAJohnson David Michael
Director
2,000$10.41$20,81118,000
(Indirect)
View
2022-12-28
Purchase
2022-12-30
7:01 pm
Aura Biosciences Inc.AURAJohnson David Michael
Director
4,000$9.75$39,00017,000
(Indirect)
View
2022-12-01
Purchase
2022-12-15
6:15 pm
Aura Biosciences Inc.AURAJohnson David Michael
Director
10,000$12.37$123,70015,000
(Indirect)
View
2022-06-10
Purchase
2022-06-14
9:29 pm
Aura Biosciences Inc.AURAJohnson David Michael
Director
50,000$14.33$716,30040,000
(Indirect
Direct)
View
2021-10-04
Sale
2021-10-04
9:15 pm
Zentalis Pharmaceuticals Inc.ZNTLJohnson David Michael
Director
12,896$66.35$855,58880,959
(Direct)
View
2021-04-05
Sale
2021-04-05
7:54 pm
Zentalis Pharmaceuticals Inc.ZNTLJohnson David Michael
Director
12,897$43.5$561,02188,855
(Direct)
View
2020-04-07
Purchase
2020-12-03
5:57 pm
Zentalis Pharmaceuticals Inc.ZNTLJohnson David Michael
Director
4,000$18$72,000101,752
(Direct)
View
2020-12-02
Sale
2020-12-03
5:57 pm
Zentalis Pharmaceuticals Inc.ZNTLJohnson David Michael
Director
12,896$51.39$662,747101,752
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-20
Option Award
2024-06-24
4:05 pm
N/A
2034-06-20
Aura Biosciences Inc.AURAJohnson David Michael
Director
25,000$0450,339
(Direct)
View
2024-06-21
Option Award
2024-06-21
5:07 pm
N/A
N/A
Zentalis Pharmaceuticals Inc.ZNTLJohnson David Michael
Director
48,429$0192,818
(Direct)
View
2023-06-16
Option Award
2023-06-16
5:04 pm
N/A
N/A
Zentalis Pharmaceuticals Inc.ZNTLJohnson David Michael
Director
19,059$0127,389
(Direct)
View
2023-06-07
Option Award
2023-06-09
4:56 pm
N/A
2033-06-07
Aura Biosciences Inc.AURAJohnson David Michael
Director
16,000$016,000
(Direct)
View
2022-06-15
Option Award
2022-06-17
5:07 pm
N/A
2032-06-15
Aura Biosciences Inc.AURAJohnson David Michael
Director
16,000$0205,672
(Direct)
View
2022-06-08
Option Award
2022-06-10
4:22 pm
N/A
N/A
Zentalis Pharmaceuticals Inc.ZNTLJohnson David Michael
Director
24,871$0108,330
(Direct)
View
2021-06-04
Option Award(A)
2021-12-17
5:57 pm
N/A
2031-06-03
Zentalis Pharmaceuticals Inc.ZNTLJohnson David Michael
Director
30,000$0118,855
(Direct)
View
2021-11-02
Conversion
2021-11-02
4:11 pm
N/A
N/A
Aura Biosciences Inc.AURAJohnson David Michael
Director
139,672$0139,672
(Indirect)
View
2021-10-28
Option Award
2021-10-29
7:33 pm
N/A
2031-10-27
Aura Biosciences Inc.AURAJohnson David Michael
Director
24,000$024,000
(Direct)
View

Ownership
2021-10-28
8:22 pm
N/A
N/A
Aura Biosciences Inc.AURAJohnson David Michael
Director
0$0460,839
(Indirect)
View
2021-06-04
Option Award
2021-06-08
5:26 pm
N/A
2031-06-03
Zentalis Pharmaceuticals Inc.ZNTLJohnson David Michael
Director
20,000$0108,855
(Direct)
View
2020-04-07
Option Award
2020-04-09
4:31 pm
N/A
N/A
Zentalis Pharmaceuticals Inc.ZNTLJohnson David Michael
Director
51,587$0110,648
(Direct)
View

Ownership
2020-04-03
6:04 pm
N/A
N/A
Zentalis Pharmaceuticals LLCZNTLJohnson David Michael
Director
0$089,061
(Direct)
View
(A) Indicate amendment filing.